[Two patients of immunotherapy-responsive autoimmune cerebellar ataxia fulfilled with criteria of multiple system atrophy].

Autor: Higashida K; Department of Neurology, Gifu University Graduate School of Medicine., Ono Y; Department of Neurology, Gifu University Graduate School of Medicine., Kato M; Department of Neurology, Gifu University Graduate School of Medicine., Takekoshi A; Department of Neurology, Gifu University Graduate School of Medicine., Yoshikura N; Department of Neurology, Gifu University Graduate School of Medicine., Kimura A; Department of Neurology, Gifu University Graduate School of Medicine., Shimohata T; Department of Neurology, Gifu University Graduate School of Medicine.
Jazyk: japonština
Zdroj: Rinsho shinkeigaku = Clinical neurology [Rinsho Shinkeigaku] 2024 Aug 27; Vol. 64 (8), pp. 589-593. Date of Electronic Publication: 2024 Jul 24.
DOI: 10.5692/clinicalneurol.cn-001979
Abstrakt: We report two patients with autoimmune cerebellar ataxia who fulfilled the diagnostic criteria of multiple system atrophy (MSA) and responded to immunotherapies. Patient 1 was a 72-year-old man who was diagnosed with clinically probable MSA according to Movement Disorder Society criteria. Patient 2 was a 68-year-old man who was diagnosed with clinically established MSA according to Movement Disorder Society criteria. Both patients showed cerebellar ataxia, autonomic dysfunction, and pyramidal tract signs; however, they also had atypical clinical features. Patient 1 exhibited self-‍limiting mild improvement of clinical symptoms and had inflammatory findings in his cerebrospinal fluid. Patient 2 showed a rapidly progressive clinical course. We therefore examined anti-neuronal antibodies using tissue-based immunohistochemical assays with frozen rat cerebellum sections. We detected autoantibodies that mainly reacted with the cytoplasm of Purkinje cells. The two patients then underwent immunotherapies, which led to substantial improvements in their clinical symptoms. Our findings indicate that some patients with autoimmune cerebella ataxia have clinical features that resemble MSA, and respond well to immunotherapies.
Databáze: MEDLINE